Søren Thinggaard Hansen, a 17 year-plus veteran of pension fund Industriens Pension, has joined Novo to launch a private equity program.
Søren Thinggaard Hansen has joined Denmark-based pharmaceutical firm Novo as a senior partner to set up a private equity initiative to complement its existing corporate venturing strategy.
Hansen had previously spent more than 17 years at local pension fund Industriens Pension, mainly as head of private equity.
Novo already provides seed and venture capital to development stage companies and takes significant ownership positions in well-established companies within life science through a public corporate venturing strategy.
